In conclusion, enhanced PANoptosis enrichment may sensitize GBM to anti-PD-1/PD-L1 therapies by promoting CD8+ T cell recruitment and infiltration into the tumor, as well as facilitating M1-like macrophage activation while suppressing polarization towards M2-like. Here, CD274 is linked to neoplasm.